Markets

Will the AI-discovered molecule providing Ozempic-like effects be approved for clinical trials by September 30, 2026?

Yes0%No0%
Loading...

About this market

This market resolves to Yes if Stanford Medicine or another reputable institution publicly confirms that the AI-discovered molecule, which mimics the effects of Ozempic without the side effects, receives approval to commence clinical trials by September 30, 2026. The resolution will be based on announcements from institutions, regulatory bodies, or credible science news sources.

Rules

  • Market closes at 9/30/2026.
  • Logic weighted resolution applies.